{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lantus&page=4", "query": { "intervention": "Lantus", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 306, "total_pages": 31, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lantus&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lantus&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-17T23:39:07.231Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02741687", "title": "Sitagliptin in Non-Diabetic Patients Undergoing General Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hyperglycemia" ], "interventions": [ { "name": "Sitagliptin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Supplemental insulin (insulin lispro)", "type": "DRUG" }, { "name": "Supplemental insulin (insulin aspart)", "type": "DRUG" }, { "name": "Long acting basal insulin (insulin detemir)", "type": "DRUG" }, { "name": "Long acting basal insulin (insulin glargine)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 80, "start_date": "2016-06", "completion_date": "2017-04", "has_results": true, "last_update_posted_date": "2018-06-27", "last_synced_at": "2026-10-17T23:39:07.231Z", "location_count": 2, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02741687" }, { "nct_id": "NCT00751114", "title": "Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Insulin Glargine", "type": "DRUG" }, { "name": "Sitagliptin", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "35 Years to 70 Years" }, "enrollment_count": 515, "start_date": "2008-11", "completion_date": "2011-07", "has_results": true, "last_update_posted_date": "2012-09-10", "last_synced_at": "2026-10-17T23:39:07.231Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00751114" }, { "nct_id": "NCT01136746", "title": "Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hyperglycemia" ], "interventions": [ { "name": "Human regular insulin", "type": "DRUG" }, { "name": "Insulin lispro", "type": "DRUG" }, { "name": "Insulin glargine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2011-03", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2012-11-13", "last_synced_at": "2026-10-17T23:39:07.231Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Jacksonville, Florida • Miami, Florida + 9 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Weston", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01136746" }, { "nct_id": "NCT01779362", "title": "RISE Adult Medication Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prediabetes", "Type 2 Diabetes" ], "interventions": [ { "name": "Metformin", "type": "DRUG" }, { "name": "Liraglutide", "type": "DRUG" }, { "name": "Glargine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "RISE Study Group", "sponsor_class": "NETWORK", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "20 Years to 65 Years" }, "enrollment_count": 267, "start_date": "2013-04", "completion_date": "2019-08", "has_results": true, "last_update_posted_date": "2023-05-11", "last_synced_at": "2026-10-17T23:39:07.231Z", "location_count": 4, "location_summary": "Chicago, Illinois • Indianapolis, Indiana • Seattle, Washington", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01779362" }, { "nct_id": "NCT02451137", "title": "A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Insulin glargine, 300 U/ml", "type": "DRUG" }, { "name": "Insulin glargine, 100 U/ml", "type": "DRUG" }, { "name": "Insulin detemir", "type": "DRUG" }, { "name": "Background Therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3304, "start_date": "2015-06-16", "completion_date": "2018-08-09", "has_results": true, "last_update_posted_date": "2019-09-10", "last_synced_at": "2026-10-17T23:39:07.231Z", "location_count": 407, "location_summary": "Birmingham, Alabama • Gulf Shores, Alabama • Guntersville, Alabama + 304 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Gulf Shores", "state": "Alabama" }, { "city": "Guntersville", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT02451137" }, { "nct_id": "NCT00338104", "title": "Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hyperglycemia", "Diabetes" ], "interventions": [ { "name": "insulin glargine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 75, "start_date": "2004-07", "completion_date": "2005-05", "has_results": true, "last_update_posted_date": "2009-04-06", "last_synced_at": "2026-10-17T23:39:07.231Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00338104" }, { "nct_id": "NCT02518945", "title": "Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "Dapagliflozin", "type": "DRUG" }, { "name": "Insulin", "type": "DRUG" }, { "name": "Liraglutide", "type": "DRUG" }, { "name": "Dapagliflozin placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University at Buffalo", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 26, "start_date": "2015-08", "completion_date": "2016-04", "has_results": true, "last_update_posted_date": "2024-01-24", "last_synced_at": "2026-10-17T23:39:07.231Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02518945" }, { "nct_id": "NCT04484779", "title": "A Study of an Insulin Management System in Participants With Type 1 or Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 1 Diabetes", "Type 2 Diabetes" ], "interventions": [ { "name": "IIM System", "type": "DEVICE" }, { "name": "Insulin Lispro and/or Insulin Glargine", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 67, "start_date": "2020-07-14", "completion_date": "2020-12-22", "has_results": false, "last_update_posted_date": "2021-01-07", "last_synced_at": "2026-10-17T23:39:07.231Z", "location_count": 5, "location_summary": "Little Rock, Arkansas • Walnut Creek, California • Austin, Texas + 2 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Austin", "state": "Texas" }, { "city": "Round Rock", "state": "Texas" }, { "city": "Renton", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04484779" }, { "nct_id": "NCT03001323", "title": "Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus" ], "interventions": [ { "name": "Degludec", "type": "DRUG" }, { "name": "Standard long-acting", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hennepin Healthcare Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2017-01", "completion_date": "2020-09-25", "has_results": false, "last_update_posted_date": "2021-05-17", "last_synced_at": "2026-10-17T23:39:07.231Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03001323" }, { "nct_id": "NCT00838916", "title": "A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "albiglutide", "type": "BIOLOGICAL" }, { "name": "insulin glargine", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 779, "start_date": "2009-02", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2017-01-09", "last_synced_at": "2026-10-17T23:39:07.231Z", "location_count": 314, "location_summary": "Alabaster, Alabama • Birmingham, Alabama • Dothan, Alabama + 252 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Hueytown", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00838916" } ] }